We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+14.7%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$195M
AUM Growth
+$20.1M
Cap. Flow
+$2.72M
Cap. Flow %
1.39%
Top 10 Hldgs %
39.92%
Holding
207
New
16
Increased
73
Reduced
68
Closed
9

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$338K
2
TMO icon
Thermo Fisher Scientific
TMO
+$331K
3
ABBV icon
AbbVie
ABBV
+$286K
4
CI icon
Cigna
CI
+$238K
5
CVX icon
Chevron
CVX
+$232K

Sector Composition

Rank Sector Weight
1 Healthcare 23.97%
2 Technology 21.73%
3 Financials 7.33%
4 Communication Services 5.72%
5 Industrials 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXJ
176
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$177K 0.09%
15,106
DB icon
177
Deutsche Bank
DB
$67.3B
$171K 0.09%
+16,700
New +$200K
FXN icon
178
First Trust Energy AlphaDEX Fund
FXN
$393M
$163K 0.08%
10,500
JMIA
179
Jumia Technologies
JMIA
$805M
$154K 0.08%
46,865
+15,490
+49% +$55.7K
ETJ
180
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$561M
$154K 0.08%
19,394
VTRS icon
181
Viatris
VTRS
$20.1B
$146K 0.07%
15,132
ET icon
182
Energy Transfer Partners
ET
$69.9B
$128K 0.07%
10,300
+300
+3% +$3.79K
STXS icon
183
Stereotaxis
STXS
$154M
$122K 0.06%
59,560
+11,300
+23% +$25.4K
HA
184
DELISTED
Hawaiian Holdings, Inc.
HA
$115K 0.06%
+12,500
New +$132K
BFX
185
DELISTED
BowFlex Inc.
BFX
$104K 0.05%
77,508
+18,500
+31% +$30.6K
FCT
186
First Trust Senior Floating Rate Income Fund II
FCT
$249M
$102K 0.05%
10,240
-483
-5% -$4.75K
VVR icon
187
Invesco Senior Income Trust
VVR
$456M
$102K 0.05%
+27,605
New +$107K
AUTL
188
Autolus Therapeutics
AUTL
$383M
$82.8K 0.04%
45,000
+2,750
+7% +$5.38K
ICCC icon
189
ImmuCell
ICCC
$101M
$80.1K 0.04%
15,667
+17
+0.1% +$110
BCS icon
190
Barclays
BCS
$93.8B
$71.9K 0.04%
10,000
ONDS icon
191
Ondas Inc
ONDS
$3.72B
$71.2K 0.04%
65,900
+18,900
+40% +$32.9K
CATX icon
192
Perspective Therapeutics
CATX
$341M
$70.2K 0.04%
11,000
HYFM icon
193
Hydrofarm Holdings
HYFM
$3.25M
$56.8K 0.03%
3,285
+1,582
+93% +$28K
IBRX icon
194
ImmunityBio
IBRX
$8.04B
$51.9K 0.03%
28,500
PVLA
195
Palvella Therapeutics
PVLA
$2.26B
$21.7K 0.01%
278
+7
+3% +$811
IMDX
196
Insight Molecular Diagnostics
IMDX
$153M
$14.4K 0.01%
2,025
AKBA icon
197
Akebia Therapeutics
AKBA
$359M
$10.3K 0.01%
18,316
HYZN
198
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$8.15K ﹤0.01%
+200
New +$14.9K
AVGO icon
199
Broadcom
AVGO
$1.76T
-6,040
Closed -$338K
BP icon
200
BP
BP
$108B
-5,728
Closed -$200K

Similar funds

Wealth Effects's Q1 2023 Portfolio in Review

As of Q1 2023, Wealth Effects held 207 positions worth $195M, up 11% from $175M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Wealth Effects's Q1 2023 filing shows 16 new, 73 increased, 68 reduced and 9 closed positions. Its largest new stake was Seelos Therapeutics, Inc. Common Stock: 249 shares worth $661K. The largest sale was Broadcom, an estimated $338K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

  • Wealth Effects's largest Q1 2023 buy was Seelos Therapeutics, Inc. Common Stock: 249 shares worth $661K.
  • Wealth Effects added most to JPMorgan Equity Premium Income ETF in Q1 2023, an estimated $511K increase.
  • Wealth Effects's biggest Q1 2023 reduction was AbbVie, cutting an estimated $286K.
  • Wealth Effects fully exited Broadcom in Q1 2023, selling an estimated $338K.
  • Wealth Effects's ten largest holdings make up 40% of its $195M portfolio in Q1 2023.
  • Wealth Effects opened 16 new positions and closed 9 in Q1 2023.
  • Wealth Effects's portfolio value rose 11% quarter-over-quarter to $195M.

Based on Wealth Effects's 13F filing for Q1 2023, filed 4 May 2023.